Quarter Ended: March 2026
Acutaas Chemicals Limited (Formerly Ami Organics) – Q4 FY26 Results
NSE
acutaas
BSE
543349
Acutaas delivered a sharp improvement in profitability and operating cash flows, indicating strong execution, though heavy capex and working capital absorption remain key themes.
key financial highlights
- Revenue from Operations:
- Revenue (Q4 FY26): ₹43,275 Cr
- QoQ Change: +10.1%
- YoY Change: +40.3%
- Previous Quarter (Q3 FY26): ₹39,318 Cr
- Previous Year (Q4 FY25): ₹30,848 Cr
- Revenue (Q4 FY26): ₹43,275 Cr
- Profit After Tax (PAT):
- PAT (Q4 FY26): ₹13,428 Cr
- QoQ Change: +26.4%
- YoY Change: +114%
- Previous Quarter (Q3 FY26): ₹10,622 Cr
- Previous Year (Q4 FY25): ₹6,271 Cr
- PAT (Q4 FY26): ₹13,428 Cr
- QoQ Performance
- Revenue Trend: Strong Growth
- Profit Trend: Strong expansion

Margin Analysis
Key Drivers:
- Operating leverage improvement
- Better cost absorption despite rising employee and other expenses
- Lower finance cost impact YoY
- Improved realization / product mix
Key Signal: Margins are expanding both QoQ and YoY, indicating strong pricing power + operating efficiency
Segment insight
Summary:
- Acutaas operates in specialty chemicals & pharma intermediates, a high-margin, export-oriented segment.
Characteristics:
- High entry barriers
- Strong client stickiness
- Export-driven revenue
- Capex-heavy expansion phase
Earning quality check
Drivers:
- Operating cash flow increased sharply to ₹29,217 Cr (vs ₹11,834 Cr YoY)
- Profit backed by real cash generation
- Minimal reliance on exceptional items
Interpretation:
- Earnings quality is very strong, supported by:
- High cash conversion
- Sustainable core business growth
balance sheet Analysis
- Total Assets: ₹1,98,396 Cr
- Total Liabilities: ₹27,321 Cr
- Total Equity: ₹1,71,075 Cr
Insight:
- Strong equity base expansion (retained earnings)
- Moderate increase in borrowings (₹2,649 Cr)
- High capex reflected in PPE jump (~₹58,279 Cr)
key risks
- Heavy capex → execution risk
- Working capital pressure (inventory & receivables increase)
- Chemical sector cyclicality
- Export demand dependency
management strategy signals
Focus Area:
- Capacity expansion (capex heavy phase)
- Specialty chemical scaling
- Export market penetration
- Product diversification
Financial Metrics
| Particular | Q4 FY26 | Q.O.Q | Y.O.Y |
|---|---|---|---|
| Total Income | ₹44,386 Crore | +11.6% | +41.4% |
| PBT | ₹18,380 Crore | +27.1% | +121.0% |
| PAT | ₹13,428 Crore | +26.4% | +114.0% |
Acutaas Chemicals delivered a breakout performance, with:
- Strong revenue growth
- Significant margin expansion
- Excellent cash flow generation
Official Exchange Filing: Acutaas Chemicals Limited
Quarterly Performance Context
COST OF OPERATIONS AS % OF REVENUE
60%
NET PROFIT AS % OF REVENUE
31%
FISCAL YEAR
2025-2026
AUDIT STATUS
REVIEWED